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ABSTRACT
pepMMsMIMIC is a novel web-oriented peptidomi-
metic compound virtual screening tool based on a
multi-conformers three-dimensional (3D)-similarity
search strategy. Key to the development of
pepMMsMIMIC has been the creation of a library
of 17 million conformers calculated from 3.9 million
commercially available chemicals collected in the
MMsINC database. Using as input the 3D structure
of a peptide bound to a protein, pepMMsMIMIC
suggests which chemical structures are able to
mimic the protein–protein recognition of this natural
peptide using both pharmacophore and shape simi-
larity techniques. We hope that the accessibility of
pepMMsMIMIC (freely available at http://mms
.dsfarm.unipd.it/pepMMsMIMIC) will encourage me-
dicinal chemists to de-peptidize protein–protein
recognition processes of biological interest, thus
increasing the potential of in silico peptidomimetic
compound screening of known small molecules to
expedite drug development.
INTRODUCTION
Protein–protein interactions are central to almost every
cellular process from cell motility to DNA replication
(1). Alterations in Protein–protein interactions perturb
the normal sequence of events in the cell and contribute
to conditions such as cancer or neurodegenerative diseases
(1). Thus, understanding the normal pattern of Protein–
protein interactions can lead to the development of drugs
to ﬁght the underlying cause of diseases (1). However, for
peptide-based drug design (2), there are several major con-
siderations that limit clinical application such as: (i) rapid
degradation by many speciﬁc or non-speciﬁc peptidases
under physiological conditions; (ii) conformational ﬂexi-
bility that allows a peptide to bind to more than one
receptor or receptor subtype leading to undesirable side
effects; (iii) poor absorption and transportation because of
their high molecular mass or lack of speciﬁc delivery
systems (3).
Peptidomimetics are designed to circumvent some of the
above-mentioned problems associated with a natural pep-
tide. Of course, certain other properties, such as receptor
selectivity or potency, often can be substantially improved.
Hence mimetics have great potential in drug discovery. In
an effort to overcome these problems, peptidomimetic
drug design has emerged as an important tool for both
medicinal chemists and pharmacologists. This approach
has evolved into an interdisciplinary scientiﬁc endeavour
that combines medicinal chemistry, biochemistry,
pharmacology and, very recently, chemoinformatics.
In fact, one of the most challenging issues for the future
of drug discovery is the capability to incorporate the most
crucial protein surface recognition properties, usually dis-
played in another peptide sequence, into a small organic
molecule. With this purpose, we have designed
pepMMsMIMIC as a web-oriented peptidomimetics vir-
tual screening tool that, given a peptide three-dimensional
(3D) structure, is able to automate a multi-conformers 3D
similarity search among 17 million conformers calculated
from 3.9 million commercially available chemicals col-
lected in the MMsINC database (4).
All of pepMMsMIMIC’s functions are accessible
through a user-friendly web interface as described later
in this text.
pepMMsMIMIC PHYLOSOPHY
As anticipated in the ‘Introduction’ section,
pepMMsMIMIC is a public, web-based virtual screening
platform with the aim to suggest chemical compounds
whose essential elements (pharmacophore) mimic a
natural peptide or protein in 3D space, which hopefully
retain the ability to interact with the biological target and
produce the typical biological effect.
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peptide complex, pepMMsMIMIC design process begins
by identifying the key residues that are responsible for the
Protein–protein recognition process. In this process, the
peptide complexity is reduced and the basic pharmaco-
phore model is deﬁned by its critical structural features
(peptide annotation points) in 3D space as schematized
in Figure 1. All possible peptide pharmacophore feature
arrangements can be enumerated to form the basis of a
peptide pharmacophore bitstring.
Once generated, the pharmacophore model can be used
to screen virtual compound libraries for novel ligands,
which present the best similarity to the speciﬁc pharma-
cophore, ﬁltering a database of 3D-conformations based
on the positions of the corresponding annotation points
derived from each of the ligand conformations.
pepMMsMIMIC performs pharmacophore screenings
using a multi-conformational version of MMsINC
(multi-confMMsINC) database. Brieﬂy, MMsINC is a
free web-oriented database of commercially available
compounds containing around 4 million of non-redundant
energetically optimized 3D-chemical structures accessible
for virtual screening and chemoinformatic applications
(4). In particular, the multi-conf version is characterized
by the presence of 17 million of low energy conformers
calculated starting from each MMsINC entry. Also in
this case, all possible conformer pharmacophore feature
(conformer annotation points) arrangements can be
enumerated to form the basis of a conformer pharmaco-
phore bitstring.
To optimize the top peptide mimetic ranking selection,
pepMMsMIMIC implements two different scoring func-
tions and one consensus scoring based on the combination
of these two. In fact, taking into account that Protein–
protein complexes typically exhibit intermolecular inter-
faces with high electrostatic (chemical) and shape and
complementarity, two scoring approaches, such as phar-
macophore ﬁngerprints similarity and ultrafast shape rec-
ognition (USR) (5), have been implemented to rank and
select the best top 200 peptidomimetic candidates.
pepMMsMIMIC WORKFLOW
pepMMsMIMIC’s workﬂow is shown in Figure 2.
The crucial steps of pepMMsMIMIC architecture are
detailed as follows.
multi-conf MMsINC: conformers generation
The best ﬁve lowest-energy conformers of each
MMsINC entry (including all tautomers and ionic
states) are generated by using Rotate ver. 1.0 software
Figure 1. Philosophy behind pepMMsMIMIC’s architecture.
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18.461.878 conformers.
Pharmacophore ﬁngerprints generation
Both L- and D-amino acids, as well as phospho-amino
acids, are labelled with the following pharmacophoric
features: tryptophan side chain, tyrosine side chain, histi-
dine side chain; H-bond acceptor, H-bond donor, posi-
tively ionisable, negatively ionisable, aromatic and
hydrophobic, as summarized in Table 1.
Both peptide and conformer annotation points ensem-
bles were described in terms of three-point pharmaco-
phores, in which every possible pair of centroids is
binned according to the feature distances. There are several
works in which pharmacophore ﬁngerprints applied for
comparison of protein–ligand recognition in their binding
sites are described (6,7). In the present work, we success-
fully apply this method for the similarity between peptides
and ligands pharmacophore ﬁngerprints.
The ﬁrst criterion used to encode triplets of pharmaco-
phoric points into the pepMMsMIMIC bitstring is based
on atom type recognition. All the possible three-point
combinations using the above-mentioned nine different
centroid types (ARO, aromatic; HYD, hydrophobic;
HAC, H-bond acceptor; HDO, H-bond donor; HIS, his-
tidine side chain; NCH, negatively ionizable; PCH, posi-
tively ionizable; TRP, tryptophan side chain; and TYR,
tyrosine side chain) are encoded in the pepMMsMIMIC
bitstring.
Centroids are deﬁned by contiguous atoms with atoms
labelled with the same pharmacophoric type (i.e. the six
carbon atoms of a benzene ring deﬁne an aromatic
centroid localized at the centre of the ring). More than
one label can be assigned to each atom. Thus, each
atom can be part of more than one centroid.
Labels were assigned with an in-house SMARTS
mapping tool based on the Chemistry Development Kit
(CDK) Java libraries (8,9).
The second criterion used to encode triplets is based on
centroid distances. According to the FuzCav method (10),
we used a maximum distance cutoff of 14.3 A ˚ and a
distance binning deﬁned as follows: [0, 4.8], [4.8, 7.2],
[7.2, 9.5], [9.5, 11.9], [11.9, 14.3]. For each class of inter-
action (i.e. ARO–ARO–PCH,...,HDO–HYD–ARO),
distance ranges according to the scheme reported below:
ARO–ARO–PCH [0, 4.8][0, 4.8][0, 4.8],...,ARO–ARO–
PCH [0, 4.8][0, 4.8][11.9, 14.3]
ARO–ARO–PCH [0, 4.8][4.8, 7.2][0, 4.8],...,ARO–
ARO–PCH [0, 4.8][4.8, 7.2][11.9, 14.3]
ARO–ARO–PCH [0, 4.8][7.2, 9.5][0, 4.8],...,ARO–
ARO–PCH [0, 4.8][7.2, 9.5][11.9, 14.3]
ARO–ARO–PCH [0, 4.8][9.5, 11.9][0, 4.8],...,ARO–
ARO–PCH [0, 4.8][9.5, 11.9][11.9, 14.3]
ARO–ARO–PCH [0, 4.8][11.9, 14.3][0, 4.8],...,ARO–
ARO–PCH [0, 4.8][11.9, 14.3][11.9, 14.3]
ARO–ARO–PCH [4.8, 7.2][0, 4.8][0, 4.8],...,ARO–
ARO–PCH [4.8, 7.2][0, 4.8][11.9, 14.3]
ARO–ARO–PCH [4.8, 7.2][4.8, 7.2][0, 4.8],...,ARO–
ARO–PCH [4.8, 7.2][4.8, 7.2][11.9, 14.3]
Using this scheme, each bin is associated with a spe-
ciﬁc triplet of interaction deﬁned by the type of the
vertices comprising the triplet and the relative distances
between each centroid pairs. Due to the class deﬁnition,
Figure 2. pepMMsMIMIC’s workﬂow.
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ARO (triplet) belongs to the same triplets of interaction
ARO–ARO–PCH. Every time a triplet is made of two
aromatic centroids and one positively ionizable centroid,
the ﬁrst criterion will be used to associate it with the class
ARO–ARO–PCH, and the second criterion (based on
atom pair distances) will be used to correctly locate the
triplet inside the ARO–ARO–PCH class within the
pepMMsMIMIC bitstring. The same rule is applied to
all three-point pharmacophore (ARO–ARO–ARO, ARO–
NCH–PCH,...,HYD–HYD–HYD) combinations.
The same classiﬁcation scheme is adopted for both
ligands and peptide residues, with the difference that one
or more pharmacophoric points are assigned to the geo-
metric centre of the side chains according to the classiﬁ-
cation reported in Table 1.
The ﬁngerprint is a vector with possible 19.815 bits;
among them, only 12.448 bits were populated in our
virtual library.
Finally, only those conformers for which at least three
spatially distinct features were retained. We stored both
USR descriptors and ﬁngerprints for a total of 17.713.005
conformers.
USR methodology
The USR, introduced by Ballester and Richards (5), is a
fast 3D similarity search method based on the assumption
that the shape of a molecule is uniquely determined by the
relative position of its atoms. The approach is based on
moments of distance distributions, and it has been success-
fully applied to the fast identiﬁcation of similarly shaped
compounds within large molecular databases.
In the USR encoding, the shape of the atomic ensemble
(a molecule or any generic set of atoms) is characterized
by the distributions of atomic distances to four reference
locations: the molecular centroid (ctd), the closest atom to
ctd (cst), the farthest atom to ctd (fct) and the farthest
Table 1. List of amino acid side-chain annotations
Aminoacid side chain Hydrophobic Positive
ionizable
Negative
ionizable
H-bond
donor
H-bond
acceptor
Aromatic Other
Alanine V
Arginine VV V
Asparagine VV
Aspartic acid VV
Cysteine V
Glutamine VV
Glutamic acid VV
Histidine VV V His ring
D-Histidine VV V His ring
Isoleucine V
Leucine V
Lysine VV
Methionine V
Phenylalanine V V
Proline V
Serine VV
Threonine VV V
Tryptophan VV Trp ring
Tyrosine VV V Tyr ring
Valine V
O-phosphotyrosine VV
Phosphoserine V
Phosphothreonine VV
D-Phosphothreonine VV
D-Alanine V
D-Arginine VV V
D-Asparagine VV
D-Aspartic acid VV
D-Cysteine V
D-Glutamine VV
D-Glutamic acid VV
D-Histidine VV V His ring
D-Isoleucine V
D-Leucine V
D-Methionine V
D-Phenylalanine V V
D-Proline V
D-Serine VV
D-Threonine VV V
D-Tryptophan VV Trp ring
D-Tyrosine VV Tyr ring
D-Valine V
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described through its ﬁrst three vectors. In this way,
each molecule (or atomic ensemble) has associated a
vector of 12 shape descriptors.
Ballester and Richards (5) proposed in their original
paper the use of this method for fast similarity compari-
sons between macromolecules; here we extend the use of
USR method to the comparison between a collection of
ligands and a protein atomic ensemble. Our in-house
Python implementation of the USR algorithm (available
on request to the Authors) has been used to calculate the
USR descriptors for the whole data set and it is used for
the on-the-ﬂy calculation of protein atoms ensemble
deﬁned by the user’s selection.
Scoring metrics
Fingerprints focusing methods commonly use similarity
coefﬁcients, such as Tanimoto, to retrieve or classify com-
pounds out of a typically large chemical library. However,
the results of similarity searching are often systematically
affected by bit density differences between reference and
database molecules. For example, in a previous study,
Tversky similarity calculations showed apparent asym-
metric behaviour because optimal search performance
was achieved by assigning higher weights on bit settings
of reference than database compounds. For Tversky simi-
larity calculations, such biasing effects could be corrected
by introducing the weighted Tversky coefﬁcient, which
made possible to set relative weights on ‘10 and ‘00 bits
and thereby balance complexity differences between refer-
ence and database molecules. In the current version of
pepMMsMMIC, ﬁngerprints similarity measure has been
implemented, based on a weighted similarity index (Sw)
calculated as below:
Sw ¼ c=ðc+2:5   mÞ
where c is the number of common bits between the peptide
query ﬁngerprint and conformer’s ﬁngerprint, and m is the
count of bits on in the query ﬁngerprint but not conform-
er’s ﬁngerprint.
Four different scoring methods are actually imple-
mented in the current version of pepMMsMIMIC:
(i) shape score (ShS) based on the USR methods;
(ii) pharmacophoric ﬁngerprint similarity (PFS) based
on weighted similarity coefﬁcient (Sw);
(iii) combined ShS and PFS ﬁltering: conformers are pri-
marily ﬁltered by using a ShS score threshold (which
must be  0.5) and subsequently sorted by PFS;
(iv) weighted ShS and PFS approach: in order to re-
duce the number of false positives, we introduced
an hybrid scoring function where a weighted com-
bination of the ShS and PFS based on weighted
similarity coefﬁcient (Sw) is combined as reported
below:
ShSandPSF ¼ð 0:4   ShSÞ+ð0:6   PFSÞ:
Weight terms were chosen based on a preliminary
in-house validation.
QUERYING pepMMsMIMIC
The pepMMsMIMIC is accessible to the public via our
web application. It allows users to easily upload a PDB
structure and to manage it using Jmol interface (7,8).
The selection of the key residues that are responsible for
the Protein–protein recognition process is intuitively
carried out either by picking them up from the Jmol inter-
face or by selecting them from the amino acids list avail-
able on the left side of the webpage.
For each selected amino acid, users can speciﬁcally
decide which pharmacophoric feature to include in the an-
notation process. In the present-version pepMMsMIMIC,
Figure 3. pepMMsMIMIC’s main screen.
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from the carbamide bonds of the protein backbone as well
the corresponding side chain moiety. At least three
interactors are required for starting a search process:
this means that in principle one residue alone is enough
for a search run if all the three features are selected.
All selected amino acids are clearly labelled in the Jmol
interface (Figure 3).
As previously described, before running pepMMsMIMIC
search, users can also decide with scoring approach use to
rank and select the best top 200 peptidomimetic candi-
dates. If more than one conformers associated with a
speciﬁc chemical compound are ranked among the top
200, only the best scored conformer will be retrieved.
The combined ShS and PFS ﬁltering scoring is selected
as default only because it got the best scoring performance
in our preliminary validation analysis.
During the search process, the temporary best scored
candidate will appear on the main pepMMsMIMIC
webpage, and it will be automatically updated as soon
as a novel best scored candidate will be found. A
complete search run requires from 15 to 20min, depending
on the search method (USR is faster than combined
methods).
Displaying peptidomimetic candidates query results
The best top 200 peptidomimetic candidates are ﬁnally
displayed as soon as the search run is completed. They
are sorted in numeric order, from the highest to the
lowest score value (Figure 4).
For each result, the pepMMsMIMIC displays the
chemical structure of conformer and its MMsCode (as
an example: the candidate ‘MMs00868010_c4’ refers to
the conformer number 4 of the MMsINC entry 00868010).
Clicking on the MMsCode of each peptidomimetic can-
didate the user will get the molecule report of MMsINC
database (Figure 5). The report shows basic information
about the molecule like the compound type (neutral,
tautomer or ionic state), the molecular formula, and its
InChI and SMILES representations. The report also
contains a 2D image of the molecule, and a 3D movable
rendering of molecule shown using Chemis3D (http://
chemis.free.fr/mol3d/) Java applet. In addition, the
pre-calculated descriptors for the molecule are listed at
the bottom of the report. Finally, for neutral molecules
the system lists all its tautomers and ions, while for tauto-
mers and ions the neutral state of the molecule is
indicated.
Moreover users can easily download, as .sdf ﬁle, the struc-
tures of all peptidemimetic candidates for further in-house
processing and analysis. Single Autodock input ﬁles can also
b er e t r i e v e df r o me a c hm o l e c u l ereport page, thus providing
an easier integration with molecular docking tools.
Implementation
The pepMMsMIMIC system is installed on a server running
Linux. The system’s web application has been developed in
PHP, with some components written in Java and Python.
pepMMsMIMIC uses the Chemistry Development Kit
(CDK) to perform some of its molecular analyses.
Figure 4. pepMMsMIMIC’s peptidometic candidates result screen.
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With the aim to validate the quality of pepMMsMIMIC
candidates selection, ﬁve known MDM2/p53 Protein–
protein inhibitors, belong to the class of Nutlins (11),
have been voluntarily included into MMsINC
database. Their structures are summarized in Table 2.
Interestingly, starting from the crystallographic structure
of MDM2/p53 complex reported in our demo key-study
(PDB code: 1YCR), all ﬁve nutlin analogues were ranked
among the top 0.6% of the entire multiconfMMsINC
database using the combined ShS and PFS ﬁltering.
Although preliminary, these results are surely
encouraging. However, further validation analyses are in
progress in our laboratories.
CONCLUSION
Gigantic amounts of genomic and proteomic data creates
high demand for synthesis and screening of nature-like
biopolymers and their more stable modiﬁed derivatives.
Design and synthesis of peptidomimetics are import-
ant because of the dominant position peptide and
Protein–protein interactions that play a role in molecular
recognition and signalling, especially in living systems.
Examination of the vast literature would suggest that
medicinal and organic chemists, who deal with peptide
mimics utilize these methods in many different ways. In
any case, a variety of methodologies and strategies have
been developed and continue to be developed to establish
systematic tools for transformation of peptides into pepti-
domimetics or further into small drug-like molecules.
Signiﬁcant industrial as well as academic resources are
invested in this effort and there is still much to learn to
optimize these approaches. We envision that peptido-
mimetic research will continue to be an indispensable
tool of structure–activity relationships in drug discovery
for the foreseeable future.
We hope that the accessibility of pepMMsMIMIC will
encourage chemists to de-peptidize Protein–protein recog-
nition processes of biological interest, thus increasing the
potential of in silico peptidomimetic candidates screening
of known small molecules to expedite drug development.
Further integration with consolidated virtual screening
tools, such as pharmacophore screening and molecular
docking, will be available in the next release of
pepMMsMIMIC.
Citing
If you refer to pepMMsMIMIC tool and web interface for
your published research, we ask that you please cite this
article.
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